Evidence map›Paper›PMID 29444822›Full record

ArticleThe Journal of biological chemistry2018

The protein kinase PERK/EIF2AK3 regulates proinsulin processing not via protein synthesis but by controlling endoplasmic reticulum chaperones.

Carrie R Sowers, Rong Wang, Rebecca A Bourne, Barbara C McGrath, Jingjie Hu, Sarah C Bevilacqua, James C Paton, Adrienne W Paton, Sophie Collardeau-Frachon, Marc Nicolino and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Co-opting regulation bypass repair as a gene-correction strategy for monogenic diseases.Molecular therapy : the journal of the American Society of Gene Therapy · 2021
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Carrie R SowersFrom the Department of Biology, Penn State University, University Park, Pennsylvania 16802.
Rong WangFrom the Department of Biology, Penn State University, University Park, Pennsylvania 16802.
Rebecca A BourneFrom the Department of Biology, Penn State University, University Park, Pennsylvania 16802.
Barbara C McGrathFrom the Department of Biology, Penn State University, University Park, Pennsylvania 16802.
Jingjie HuFrom the Department of Biology, Penn State University, University Park, Pennsylvania 16802.
Sarah C BevilacquaFrom the Department of Biology, Penn State University, University Park, Pennsylvania 16802.
James C Patonthe Department of Molecular and Cellular Biology, Research Centre for Infectious Diseases, University of Adelaide, Adelaide 5005, Australia.
Adrienne W Patonthe Department of Molecular and Cellular Biology, Research Centre for Infectious Diseases, University of Adelaide, Adelaide 5005, Australia.
Sophie Collardeau-Frachonthe Department of Pathology, Hôpital-Femme-Mère-Enfant, Hospices Civils de Lyon, Université Claude Bernard Lyon I and CarMeN, INSERM Unit U1060, 69677 Bron, France, and.ORCID 0000-0001-8604-1089
Marc Nicolinothe Service d'endocrinologie et de diabétologie pédiatriques et maladies héréditaires du métabolisme, Hôpital Femme-Mère-Enfant, Hospices Civils de Lyon, F-69677 Bron, France.ORCID 0000-0001-5395-2249
Douglas R CavenerFrom the Department of Biology, Penn State University, University Park, Pennsylvania 16802, drc9@psu.edu.ORCID 0000-0002-1558-7137
Pennsylvania State University · USThe University of Adelaide · AUHôpital Femme Mère Enfant · FRUniversité Claude Bernard Lyon 1 · FR

Funding

Physiological Regulation of Proinsulin Quality and Quantity Control in the PancreR01DK088140 · NIDDK · PENNSYLVANIA STATE UNIVERSITY, THE · PI CAVENER, DOUGLAS R. · 2010 to 2018
$2.6M
NIDDK NIH HHS R01 DK088140
6 · The paper itself

Abstract

Loss-of-function mutations of the protein kinase PERK (EIF2AK3) in humans and mice cause permanent neonatal diabetes and severe proinsulin aggregation in the endoplasmic reticulum (ER), highlighting the essential role of PERK in insulin production in pancreatic β cells. As PERK is generally known as a translational regulator of the unfolded protein response (UPR), the underlying cause of these β cell defects has often been attributed to derepression of proinsulin synthesis, resulting in proinsulin overload in the ER. Using high-resolution imaging and standard protein fractionation and immunological methods we have examined the PERK-dependent phenotype more closely. We found that whereas proinsulin aggregation requires new protein synthesis, global protein and proinsulin synthesis are down-regulated in PERK-inhibited cells, strongly arguing against proinsulin overproduction being the root cause of their aberrant ER phenotype. Furthermore, we show that PERK regulates proinsulin proteostasis by modulating ER chaperones, including BiP and ERp72. Transgenic overexpression of BiP and BiP knockdown (KD) both promoted proinsulin aggregation, whereas ERp72 overexpression and knockdown rescued it. These findings underscore the importance of ER chaperones working in concert to achieve control of insulin production and identify a role for PERK in maintaining a functional balance among these chaperones.

Indexed as

AnimalsDiabetes MellituseIF-2 KinaseEndoplasmic ReticulumGlucoseHumansInsulinInsulin-Secreting CellsMiceMice, KnockoutMolecular ChaperonesProinsulinProtein BiosynthesisUnfolded Protein ResponseEIF2AK3 protein, humaneIF-2 KinaseGlucoseInsulinMolecular ChaperonesProinsulinbeta cellsBiPchaperoneendoplasmic reticulum (ER)insulin secretionintracellular traffickingPERKprotein aggregation

Identifiers

PMID29444822
PMCPMC5892574
OpenAlexW2786412717

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.